pharmaceuticals-and-healthcare

United States Oral Vaccines Market Report 2017


Published On : Apr 2017

Category : Pharmaceutical

No. of Pages : 106 pages

  • $3800
  • $7600

Please click below to avail discount on this report

In this report, the United States Oral Vaccines market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022.

Geographically, this report splits the United States market into seven regions:
The West
Southwest
The Middle Atlantic
New England
The South
The Midwest
with sales (volume), revenue (value), market share and growth rate of Oral Vaccines in these regions, from 2012 to 2022 (forecast).

United States Oral Vaccines market competition by top manufacturers/players, with Oral Vaccines sales volume, price, revenue (Million USD) and market share for each manufacturer/player; the top players including
GlaxoSmithKline Plc.
PaxVax Corporation
Merial, Inc.
Merck Sharp & Dohme Corp
VALNEVA Canada Inc.
QUMICA SUIZA S.A
Immunitor, Inc
Aventis (Sanofi S.A.)
Serum Institute of India Pvt. Ltd
Swiss Serum and Vaccine Institute Berne
Bull Bio - NCIPD Ltd.
Vaxart, Inc.
Shantha Biotechnics
Crucell (Janssen Global Services, LLC)

On the basis of product, this report displays the sales volume, revenue, product price, market share and growth rate of each type, primarily split into
Live Attenuated Vaccines
Killed/Inactivated Vaccines
Recombinant Vaccines
Others
On the basis on the end users/applications, this report focuses on the status and outlook for major applications/end users, sales volume, market share and growth rate of Oral Vaccines for each application, including
Polio
Rabies
Rotavirus
Cholera
HIV
Respiratory Infections
Influenza
Tuberculosis
Others

In the recent times, the global market for United states oral vaccines market report 2017 has surfaced as one of the most promising markets in the pharmaceutical industry, thanks to the significant rise in research and development activities by leading vendors of United states oral vaccines market report 2017 across the world. Manufacturers have turned to technological innovations and data-driven customization to satisfy the augmenting consumer demand for efficiency and more accuracy in results, leading to an increased usage of technology in the United states oral vaccines market report 2017 production processes, which is also reflecting positively on the growth of this market.

The research report on the United states oral vaccines market report 2017 is an analytical study which comprehensively analyzes the competitive framework of this market. Using a number of effective assessment tools, such as porter’s five forces and value chain analysis, it performs in-depth analyses of the production and supply as well as the demand and sales of United states oral vaccines market report 2017 and provides deep insights into the future prospects of this market.

The study begins with a detailed overview of the market for United states oral vaccines market report 2017, including the definition, classification, and industry chain structure of United states oral vaccines market report 2017, and move forward to cover every aspect of this market, counting several criteria based on which the market is classified. Focusing specifically on the key trends, it further evaluates the overall performance of this market during the assessment period. With chemical industry undergoing a phase of technological disruption, innovations in products are likely to shape the future of the United states oral vaccines market report 2017.

In this research report, apart from the trends, the driving forces, restraints, and opportunities have also been taken into consideration to determine the market’s future. Further, it offers an estimation of the market size in terms of value (US$) and in volume (kilo tons) and talks about the key segments and the geographical subdivisions of the market for United states oral vaccines market report 2017 in details. It provides in-depth information on the development trends and the policies and regulations, concerning United states oral vaccines market report 2017, implemented in each of the geographical segments. The predominant applications of the United states oral vaccines market report 2017 have also been discussed at length in this research study.

With all these analyses and information, this report can act as a valuable guide to readers looking to gain a clear understanding of all the factors that are influencing the market for United states oral vaccines market report 2017 at present and are projected to remain doing so over the forecast period. Readers will also benefit significantly from the important information regarding this market, provided in the forms of figures and tables in the research report.

Additionally, the information on the latest developments in this market, both, at the global as well as regional level, is expected to enhance the decision-making capability of the reader. Up-to-date information on various specifications, buyer analysis, their purchasing volume, prices, and price analysis, and deep insights on the leading suppliers have also been provided in this study for the readers.

At last, the report offers key industry recommendations to companies looking to venture into the United states oral vaccines market report 2017 from both the perspectives, i.e. demand and supply. The main objective of this research study is to assist stakeholders operating in this market in creating efficient counter strategies to gain an edge over their competitors.

List of Tables and Figures

Figure Product Picture of Oral Vaccines
Figure United States Oral Vaccines Market Size (K Pcs) by Type (2012-2022)
Figure United States Oral Vaccines Sales Volume Market Share by Type (Product Category) in 2016
Figure Live Attenuated Vaccines Product Picture
Figure Killed/Inactivated Vaccines Product Picture
Figure Recombinant Vaccines Product Picture
Figure Others Product Picture
Figure United States Oral Vaccines Market Size (K Pcs) by Application (2012-2022)
Figure United States Sales Market Share of Oral Vaccines by Application in 2016
Figure Polio Examples
Figure Rabies Examples
Figure Rotavirus Examples
Figure Cholera Examples
Figure HIV Examples
Figure Respiratory Infections Examples
Figure Influenza Examples
Figure Tuberculosis Examples
Figure Others Examples
Figure United States Oral Vaccines Market Size (Million USD) by Region (2012-2022)
Figure The West Oral Vaccines Revenue (Million USD) and Growth Rate (2012-2022)
Figure Southwest Oral Vaccines Revenue (Million USD) and Growth Rate (2012-2022)
Figure The Middle Atlantic Oral Vaccines Revenue (Million USD) and Growth Rate (2012-2022)
Figure New England Oral Vaccines Revenue (Million USD) and Growth Rate (2012-2022)
Figure The South of US Oral Vaccines Revenue (Million USD) and Growth Rate (2012-2022)
Figure The Midwest Oral Vaccines Revenue (Million USD) and Growth Rate (2012-2022)
Figure United States Oral Vaccines Sales (K Pcs) and Growth Rate (2012-2022)
Figure United States Oral Vaccines Revenue (Million USD) and Growth Rate (2012-2022)
Figure United States Oral Vaccines Market Major Players Product Sales Volume (K Pcs) (2012-2017)
Table United States Oral Vaccines Sales (K Pcs) of Key Players/Suppliers (2012-2017)
Table United States Oral Vaccines Sales Share by Players/Suppliers (2012-2017)
Figure 2016 United States Oral Vaccines Sales Share by Players/Suppliers
Figure 2017 United States Oral Vaccines Sales Share by Players/Suppliers
Figure United States Oral Vaccines Market Major Players Product Revenue (Million USD) (2012-2017)
Table United States Oral Vaccines Revenue (Million USD) by Players/Suppliers (2012-2017)
Table United States Oral Vaccines Revenue Share by Players/Suppliers (2012-2017)
Figure 2016 United States Oral Vaccines Revenue Share by Players/Suppliers
Figure 2017 United States Oral Vaccines Revenue Share by Players/Suppliers
Table United States Market Oral Vaccines Average Price (USD/Pcs) of Key Players/Suppliers (2012-2017)
Figure United States Market Oral Vaccines Average Price (USD/Pcs) of Key Players/Suppliers in 2016
Figure United States Oral Vaccines Market Share of Top 3 Players/Suppliers
Figure United States Oral Vaccines Market Share of Top 5 Players/Suppliers
Table United States Players/Suppliers Oral Vaccines Manufacturing Base Distribution and Sales Area
Table United States Players/Suppliers Oral Vaccines Product Category
Table United States Oral Vaccines Sales (K Pcs) by Region (2012-2017)
Table United States Oral Vaccines Sales Share by Region (2012-2017)
Figure United States Oral Vaccines Sales Share by Region (2012-2017)
Figure United States Oral Vaccines Sales Market Share by Region in 2016
Table United States Oral Vaccines Revenue (Million USD) and Market Share by Region (2012-2017)
Table United States Oral Vaccines Revenue Share by Region (2012-2017)
Figure United States Oral Vaccines Revenue Market Share by Region (2012-2017)
Figure United States Oral Vaccines Revenue Market Share by Region in 2016
Table United States Oral Vaccines Price (USD/Pcs) by Region (2012-2017)
Table United States Oral Vaccines Sales (K Pcs) by Type (2012-2017)
Table United States Oral Vaccines Sales Share by Type (2012-2017)
Figure United States Oral Vaccines Sales Share by Type (2012-2017)
Figure United States Oral Vaccines Sales Market Share by Type in 2016
Table United States Oral Vaccines Revenue (Million USD) and Market Share by Type (2012-2017)
Table United States Oral Vaccines Revenue Share by Type (2012-2017)
Figure Revenue Market Share of Oral Vaccines by Type (2012-2017)
Figure Revenue Market Share of Oral Vaccines by Type in 2016
Table United States Oral Vaccines Price (USD/Pcs) by Types (2012-2017)
Figure United States Oral Vaccines Sales Growth Rate by Type (2012-2017)
Table United States Oral Vaccines Sales (K Pcs) by Application (2012-2017)
Table United States Oral Vaccines Sales Market Share by Application (2012-2017)
Figure United States Oral Vaccines Sales Market Share by Application (2012-2017)
Figure United States Oral Vaccines Sales Market Share by Application in 2016
Table United States Oral Vaccines Sales Growth Rate by Application (2012-2017)
Figure United States Oral Vaccines Sales Growth Rate by Application (2012-2017)
Table GlaxoSmithKline Plc. Basic Information List
Table GlaxoSmithKline Plc. Oral Vaccines Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Figure GlaxoSmithKline Plc. Oral Vaccines Sales Growth Rate (2012-2017)
Figure GlaxoSmithKline Plc. Oral Vaccines Sales Market Share in United States (2012-2017)
Figure GlaxoSmithKline Plc. Oral Vaccines Revenue Market Share in United States (2012-2017)
Table PaxVax Corporation Basic Information List
Table PaxVax Corporation Oral Vaccines Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Figure PaxVax Corporation Oral Vaccines Sales Growth Rate (2012-2017)
Figure PaxVax Corporation Oral Vaccines Sales Market Share in United States (2012-2017)
Figure PaxVax Corporation Oral Vaccines Revenue Market Share in United States (2012-2017)
Table Merial, Inc. Basic Information List
Table Merial, Inc. Oral Vaccines Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Figure Merial, Inc. Oral Vaccines Sales Growth Rate (2012-2017)
Figure Merial, Inc. Oral Vaccines Sales Market Share in United States (2012-2017)
Figure Merial, Inc. Oral Vaccines Revenue Market Share in United States (2012-2017)
Table Merck Sharp & Dohme Corp Basic Information List
Table Merck Sharp & Dohme Corp Oral Vaccines Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Figure Merck Sharp & Dohme Corp Oral Vaccines Sales Growth Rate (2012-2017)
Figure Merck Sharp & Dohme Corp Oral Vaccines Sales Market Share in United States (2012-2017)
Figure Merck Sharp & Dohme Corp Oral Vaccines Revenue Market Share in United States (2012-2017)
Table VALNEVA Canada Inc. Basic Information List
Table VALNEVA Canada Inc. Oral Vaccines Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Figure VALNEVA Canada Inc. Oral Vaccines Sales Growth Rate (2012-2017)
Figure VALNEVA Canada Inc. Oral Vaccines Sales Market Share in United States (2012-2017)
Figure VALNEVA Canada Inc. Oral Vaccines Revenue Market Share in United States (2012-2017)
Table QUMICA SUIZA S.A Basic Information List
Table QUMICA SUIZA S.A Oral Vaccines Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Figure QUMICA SUIZA S.A Oral Vaccines Sales Growth Rate (2012-2017)
Figure QUMICA SUIZA S.A Oral Vaccines Sales Market Share in United States (2012-2017)
Figure QUMICA SUIZA S.A Oral Vaccines Revenue Market Share in United States (2012-2017)
Table Immunitor, Inc Basic Information List
Table Immunitor, Inc Oral Vaccines Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Figure Immunitor, Inc Oral Vaccines Sales Growth Rate (2012-2017)
Figure Immunitor, Inc Oral Vaccines Sales Market Share in United States (2012-2017)
Figure Immunitor, Inc Oral Vaccines Revenue Market Share in United States (2012-2017)
Table Aventis (Sanofi S.A.) Basic Information List
Table Aventis (Sanofi S.A.) Oral Vaccines Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Figure Aventis (Sanofi S.A.) Oral Vaccines Sales Growth Rate (2012-2017)
Figure Aventis (Sanofi S.A.) Oral Vaccines Sales Market Share in United States (2012-2017)
Figure Aventis (Sanofi S.A.) Oral Vaccines Revenue Market Share in United States (2012-2017)
Table Serum Institute of India Pvt. Ltd Basic Information List
Table Serum Institute of India Pvt. Ltd Oral Vaccines Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Figure Serum Institute of India Pvt. Ltd Oral Vaccines Sales Growth Rate (2012-2017)
Figure Serum Institute of India Pvt. Ltd Oral Vaccines Sales Market Share in United States (2012-2017)
Figure Serum Institute of India Pvt. Ltd Oral Vaccines Revenue Market Share in United States (2012-2017)
Table Swiss Serum and Vaccine Institute Berne Basic Information List
Table Swiss Serum and Vaccine Institute Berne Oral Vaccines Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Figure Swiss Serum and Vaccine Institute Berne Oral Vaccines Sales Growth Rate (2012-2017)
Figure Swiss Serum and Vaccine Institute Berne Oral Vaccines Sales Market Share in United States (2012-2017)
Figure Swiss Serum and Vaccine Institute Berne Oral Vaccines Revenue Market Share in United States (2012-2017)
Table Bull Bio - NCIPD Ltd. Basic Information List
Table Vaxart, Inc. Basic Information List
Table Shantha Biotechnics Basic Information List
Table Crucell (Janssen Global Services, LLC) Basic Information List
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Oral Vaccines
Figure Manufacturing Process Analysis of Oral Vaccines
Figure Oral Vaccines Industrial Chain Analysis
Table Raw Materials Sources of Oral Vaccines Major Players/Suppliers in 2016
Table Major Buyers of Oral Vaccines
Table Distributors/Traders List
Figure United States Oral Vaccines Sales Volume (K Pcs) and Growth Rate Forecast (2017-2022)
Figure United States Oral Vaccines Revenue (Million USD) and Growth Rate Forecast (2017-2022)
Figure United States Oral Vaccines Price (USD/Pcs) Trend Forecast (2017-2022)
Table United States Oral Vaccines Sales Volume (K Pcs) Forecast by Type (2017-2022)
Figure United States Oral Vaccines Sales Volume (K Pcs) Forecast by Type (2017-2022)
Figure United States Oral Vaccines Sales Volume (K Pcs) Forecast by Type in 2022
Table United States Oral Vaccines Sales Volume (K Pcs) Forecast by Application (2017-2022)
Figure United States Oral Vaccines Sales Volume (K Pcs) Forecast by Application (2017-2022)
Figure United States Oral Vaccines Sales Volume (K Pcs) Forecast by Application in 2022
Table United States Oral Vaccines Sales Volume (K Pcs) Forecast by Region (2017-2022)
Table United States Oral Vaccines Sales Volume Share Forecast by Region (2017-2022)
Figure United States Oral Vaccines Sales Volume Share Forecast by Region (2017-2022)
Figure United States Oral Vaccines Sales Volume Share Forecast by Region in 2022
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources

Send an Enquiry

  • * :
  • * :
  • * :
  • * :
  • * :
  • :
  • * :
  • * indicates required field.

LATEST NEWS


Back To Top